OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F3405, issued on July 21, 2026, for the delivery of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068. This award is executed as a delivery order under the existing contract SPE2DX25D9900 and is intended to support federal medical supply needs. The total contract value is specified in the award documentation, and the performance location and detailed address information are not provided, though the contractor operates under a U.S. federal procurement framework. The award type is classified as a federal award with no set-aside designation, and the purchasing agency is the Department of Defense via the Defense Logistics Agency. The official record can be accessed through the DIBBS system using the provided UI link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
